Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anshen Bunao Ye is a Traditional Chinese Medicine (TCM) oral liquid developed and manufactured by Jilin Aodong Yanbian Pharmaceutical, a subsidiary of Jilin Aodong Pharmaceutical Group. The formulation is a combination of six herbal ingredients—deer antler (Cervus elaphus), prepared Polygonum multiflorum (He Shou Wu), Epimedium (Yin Yang Huo), dried ginger, licorice, and Chinese jujube—supplemented with Vitamin B1 (thiamine). It is primarily indicated for the treatment of neurasthenia and associated symptoms such as insomnia, excessive dreaming, forgetfulness, dizziness, tinnitus, memory decline, headache, and fatigue. In TCM theory, the product functions to tonify the kidney, nourish the essence, and benefit the brain. It is approved and marketed in China as an over-the-counter (OTC) medication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Anshen Bunao Ye.